{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:39:31Z","timestamp":1779907171806,"version":"3.53.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.7759\/cureus.23785","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:35:26Z","timestamp":1648996526000},"source":"Crossref","is-referenced-by-count":23,"title":["Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management"],"prefix":"10.7759","author":[{"given":"Rabia","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajkumar B","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Vanessa","family":"Flores Monar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Madhurima","family":"Puttagunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hepatic lipocytes, TIMP-1 and liver fibrosis","volume":"28","author":"Arthur MJ","year":"1994","unstructured":"Arthur MJ, Iredale JP. Hepatic lipocytes, TIMP-1 and liver fibrosis. J R Coll Physicians Lond. 1994, 28:200-8.","journal-title":"J R Coll Physicians Lond"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale JP","year":"2007","unstructured":"Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007, 117:539-48. 10.1172\/JCI30542","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(02)00199-x","article-title":"Haemostatic abnormalities in patients with liver disease","volume":"37","author":"Lisman T","year":"2002","unstructured":"Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002, 37:280-7. 10.1016\/s0168-8278(02)00199-x","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.06.008","article-title":"Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?","volume":"55","author":"Violi F","year":"2011","unstructured":"Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?. J Hepatol. 2011, 55:1415-27. 10.1016\/j.jhep.2011.06.008","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i35.10062","article-title":"Coagulopathy in liver disease: lack of an assessment tool","volume":"21","author":"Blasi A","year":"2015","unstructured":"Blasi A. Coagulopathy in liver disease: lack of an assessment tool. World J Gastroenterol. 2015, 21:10062-71. 10.3748\/wjg.v21.i35.10062","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis","volume":"117","author":"Ambrosino P","year":"2017","unstructured":"Ambrosino P, Tarantino L, Di Minno G, et al.. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost. 2017, 117:139-48. 10.1160\/TH16-06-0450","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.27","article-title":"Cirrhosis is associated with an increased 30-day mortality after venous thromboembolism","volume":"6","author":"S\u00f8gaard KK","year":"2015","unstructured":"S\u00f8gaard KK, Horv\u00e1th-Puh\u00f3 E, Montomoli J, Vilstrup H, S\u00f8rensen HT. Cirrhosis is associated with an increased 30-day mortality after venous thromboembolism. Clin Transl Gastroenterol. 2015, 6:e97. 10.1038\/ctg.2015.27","journal-title":"Clin Transl Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz A","year":"2016","unstructured":"Drolz A, Horvatits T, Roedl K, et al.. Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology. 2016, 64:556-68. 10.1002\/hep.28628","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman T","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010, 116:878-85. 10.1182\/blood-2010-02-261891","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-009-0302-z","article-title":"Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged","volume":"5","author":"Tripodi A","year":"2010","unstructured":"Tripodi A, Primignani M, Mannucci PM. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med. 2010, 5:7-12. 10.1007\/s11739-009-0302-z","journal-title":"Intern Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.07.010","article-title":"Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions","volume":"134","author":"Groeneveld D","year":"2014","unstructured":"Groeneveld D, Porte RJ, Lisman T. Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions. Thromb Res. 2014, 134:753-6. 10.1016\/j.thromres.2014.07.010","journal-title":"Thromb Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco L","year":"2019","unstructured":"Turco L, de Raucourt E, Valla DC, Villa E. Anticoagulation in the cirrhotic patient. JHEP Rep. 2019, 1:227-39. 10.1016\/j.jhepr.2019.02.006","journal-title":"JHEP Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell SH","year":"2006","unstructured":"Caldwell SH, Hoffman M, Lisman T, et al.. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006, 44:1039-46. 10.1002\/hep.21303","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994024","article-title":"Hemostasis in advanced liver disease","volume":"19","author":"P\u00e1ramo JA","year":"1993","unstructured":"P\u00e1ramo JA, Rocha E. Hemostasis in advanced liver disease. Semin Thromb Hemost. 1993, 19:184-90. 10.1055\/s-2007-994024","journal-title":"Semin Thromb Hemost"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)49910-9","article-title":"Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor","volume":"267","author":"Savage B","year":"1992","unstructured":"Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem. 1992, 267:11300-6.","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1673658","article-title":"Coagulation pathways, hemostasis, and thrombosis in liver failure","volume":"39","author":"Intagliata NM","year":"2018","unstructured":"Intagliata NM, Davis JP, Caldwell SH. Coagulation pathways, hemostasis, and thrombosis in liver failure. Semin Respir Crit Care Med. 2018, 39:598-608. 10.1055\/s-0038-1673658","journal-title":"Semin Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of \"hypersplenic\" thrombocytopenia","volume":"45","author":"Aster RH","year":"1966","unstructured":"Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of \"hypersplenic\" thrombocytopenia. J Clin Invest. 1966, 45:645-57. 10.1172\/JCI105380","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.5.754","article-title":"Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation","volume":"44","author":"Goulis J","year":"1999","unstructured":"Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999, 44:754-8. 10.1136\/gut.44.5.754","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V83.2.404.404","article-title":"Structural changes in platelet glycoprotein IIb\/IIIa by plasmin: determinants and functional consequences","volume":"83","author":"Pasche B","year":"1994","unstructured":"Pasche B, Ouimet H, Francis S, Loscalzo J. Structural changes in platelet glycoprotein IIb\/IIIa by plasmin: determinants and functional consequences. Blood. 1994, 83:404-14.","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0026-2862(75)90070-9","article-title":"Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells","volume":"9","author":"Turitto VT","year":"1975","unstructured":"Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res. 1975, 9:335-44. 10.1016\/0026-2862(75)90070-9","journal-title":"Microvasc Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro D","year":"1996","unstructured":"Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996, 23:1377-83. 10.1002\/hep.510230613","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci PM","year":"2001","unstructured":"Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001, 98:2730-5. 10.1182\/blood.v98.9.2730","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.6.2236","article-title":"Identification and purification to near homogeneity of the vitamin K-dependent carboxylase","volume":"88","author":"Wu SM","year":"1991","unstructured":"Wu SM, Morris DP, Stafford DW. Identification and purification to near homogeneity of the vitamin K-dependent carboxylase. Proc Natl Acad Sci U S A. 1991, 88:2236-40. 10.1073\/pnas.88.6.2236","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060417","article-title":"Multivariate analysis of prognostic factors in fulminant hepatitis B","volume":"6","author":"Bernuau J","year":"1986","unstructured":"Bernuau J, Goudeau A, Poynard T, et al.. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986, 6:648-51. 10.1002\/hep.1840060417","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.35.6.667","article-title":"Acquired dysfibrinogenaemia in liver disease","volume":"35","author":"Francis JL","year":"1982","unstructured":"Francis JL, Armstrong DJ. Acquired dysfibrinogenaemia in liver disease. J Clin Pathol. 1982, 35:667-72. 10.1136\/jcp.35.6.667","journal-title":"J Clin Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113030","article-title":"Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease","volume":"79","author":"Bajaj MS","year":"1987","unstructured":"Bajaj MS, Rana SV, Wysolmerski RB, Bajaj SP. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease. J Clin Invest. 1987, 79:1874-8. 10.1172\/JCI113030","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.22.8869","article-title":"Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis","volume":"87","author":"Bajaj MS","year":"1990","unstructured":"Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A. 1990, 87:8869-73. 10.1073\/pnas.87.22.8869","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1087127","article-title":"Coagulation abnormalities in liver disease","volume":"4","author":"Lechner K","year":"1977","unstructured":"Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Hemost. 1977, 4:40-56. 10.1055\/s-0028-1087127","journal-title":"Semin Thromb Hemost"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000217178","article-title":"Protein Z, a new haemostatic factor, in liver diseases","volume":"25","author":"Kemkes-Matthes B","year":"1995","unstructured":"Kemkes-Matthes B, Matthes KJ. Protein Z, a new haemostatic factor, in liver diseases. Haemostasis. 1995, 25:312-6. 10.1159\/000217178","journal-title":"Haemostasis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman T","year":"2001","unstructured":"Lisman T, Leebeek FW, Mosnier LO, et al.. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001, 121:131-9. 10.1053\/gast.2001.25481","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.3.214","article-title":"Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease","volume":"47","author":"Leiper K","year":"1994","unstructured":"Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease. J Clin Pathol. 1994, 47:214-7. 10.1136\/jcp.47.3.214","journal-title":"J Clin Pathol"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840180611","article-title":"Activation of the fibrinolytic system in patients with fulminant liver failure","volume":"18","author":"Pernambuco JR","year":"1993","unstructured":"Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology. 1993, 18:1350-6.","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.02801.x","article-title":"AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state","volume":"94","author":"Joist JH","year":"1999","unstructured":"Joist JH. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol. 1999, 94:2801-3. 10.1111\/j.1572-0241.1999.02801.x","journal-title":"Am J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.10.016","article-title":"Bleeding and thrombosis in cirrhotic patients: what really matters?","volume":"44","author":"Ferro D","year":"2012","unstructured":"Ferro D, Angelico F, Caldwell SH, Violi F. Bleeding and thrombosis in cirrhotic patients: what really matters?. Dig Liver Dis. 2012, 44:275-9. 10.1016\/j.dld.2011.10.016","journal-title":"Dig Liver Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2007.11.010","article-title":"Spontaneous intracranial hemorrhage in cirrhotic patients","volume":"110","author":"Huang HH","year":"2008","unstructured":"Huang HH, Lin HH, Shih YL, et al.. Spontaneous intracranial hemorrhage in cirrhotic patients. Clin Neurol Neurosurg. 2008, 110:253-8. 10.1016\/j.clineuro.2007.11.010","journal-title":"Clin Neurol Neurosurg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad T","year":"2017","unstructured":"Mahfood Haddad T, Hamdeh S, Kanmanthareddy A, Alla VM. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis. Diabetes Metab Syndr. 2017, 11:S209-16. 10.1016\/j.dsx.2016.12.033","journal-title":"Diabetes Metab Syndr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis","volume":"9","author":"Stine JG","year":"2018","unstructured":"Stine JG, Niccum BA, Zimmet AN, Intagliata N, Caldwell SH, Argo CK, Northup PG. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clin Transl Gastroenterol. 2018, 9:140. 10.1038\/s41424-018-0002-y","journal-title":"Clin Transl Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","author":"Wu H","year":"2010","unstructured":"Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol. 2010, 8:800-5. 10.1016\/j.cgh.2010.05.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","author":"S\u00f8gaard KK","year":"2009","unstructured":"S\u00f8gaard KK, Horv\u00e1th-Puh\u00f3 E, Gr\u00f8nbaek H, Jepsen P, Vilstrup H, S\u00f8rensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol. 2009, 104:96-101. 10.1038\/ajg.2008.34","journal-title":"Am J Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0265-3","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhosis patients","volume":"53","author":"Gulley D","year":"2008","unstructured":"Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008, 53:3012-7. 10.1007\/s10620-008-0265-3","journal-title":"Dig Dis Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup PG","year":"2006","unstructured":"Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH, Berg CL. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006, 101:1524-8. 10.1111\/j.1572-0241.2006.00588.x","journal-title":"Am J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano L","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, et al.. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004, 40:736-41. 10.1016\/j.jhep.2004.01.001","journal-title":"J Hepatol"},{"key":"ref43","article-title":"Ongoing prothrombotic state in the portal circulation of cirrhotic patients","volume":"77","author":"Violi F","year":"1997","unstructured":"Violi F, Ferro D, Basili S, et al.. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost. 1997, 77:44-7.","journal-title":"Thromb Haemost"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis EA","year":"2010","unstructured":"Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010, 31:366-74. 10.1111\/j.1365-2036.2009.04182.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.06.018","article-title":"Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease","volume":"8","author":"Giannini EG","year":"2010","unstructured":"Giannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010, 8:899-902. 10.1016\/j.cgh.2010.06.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28853","article-title":"Low-grade endotoxemia and platelet activation in cirrhosis","volume":"65","author":"Raparelli V","year":"2017","unstructured":"Raparelli V, Basili S, Carnevale R, et al.. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology. 2017, 65:571-81. 10.1002\/hep.28853","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.007","article-title":"Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure","volume":"61","author":"Terrault NA","year":"2014","unstructured":"Terrault NA, Hassanein T, Howell CD, et al.. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol. 2014, 61:1253-9. 10.1016\/j.jhep.2014.07.007","journal-title":"J Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.8635","article-title":"Viscoelastic testing in liver disease","volume":"17","author":"Davis JP","year":"2018","unstructured":"Davis JP, Northup PG, Caldwell SH, Intagliata NM. Viscoelastic testing in liver disease. Ann Hepatol. 2018, 17:205-13. 10.5604\/01.3001.0010.8635","journal-title":"Ann Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80107-x","article-title":"Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis","volume":"30","author":"Aub\u00e9 C","year":"1999","unstructured":"Aub\u00e9 C, Oberti F, Korali N, et al.. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol. 1999, 30:472-8. 10.1016\/s0168-8278(99)80107-x","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-007-9200-x","article-title":"Portal vein thrombosis: CT features","volume":"33","author":"Lee HK","year":"2008","unstructured":"Lee HK, Park SJ, Yi BH, Yeon EK, Kim JH, Hong HS. Portal vein thrombosis: CT features. Abdom Imaging. 2008, 33:72-9. 10.1007\/s00261-007-9200-x","journal-title":"Abdom Imaging"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.155.6.2122672","article-title":"Bright pleural effusion and ascites on gradient-echo MR images: a potential source of confusion in vascular MR studies","volume":"155","author":"Wallner B","year":"1990","unstructured":"Wallner B, Edelman RR, Finn JP, Mattle HP. Bright pleural effusion and ascites on gradient-echo MR images: a potential source of confusion in vascular MR studies. AJR Am J Roentgenol. 1990, 155:1237-40. 10.2214\/ajr.155.6.2122672","journal-title":"AJR Am J Roentgenol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198210000-00011","article-title":"The risk of bleeding after percutaneous liver biopsy: relation to platelet count","volume":"4","author":"Sharma P","year":"1982","unstructured":"Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol. 1982, 4:451-3. 10.1097\/00004836-198210000-00011","journal-title":"J Clin Gastroenterol"},{"key":"ref53","article-title":"Changing perspectives in portal vein thrombosis","author":"Janssen HL","year":"2000","unstructured":"Janssen HL. Changing perspectives in portal vein thrombosis. Scand J Gastroenterol Suppl. 2000, 69-73.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1802932","article-title":"The use of thrombopoietin receptor agonists for correction of thrombocytopenia prior to elective procedures in chronic liver diseases: review of current evidence","volume":"2016","author":"Qureshi K","year":"2016","unstructured":"Qureshi K, Patel S, Meillier A. The use of thrombopoietin receptor agonists for correction of thrombocytopenia prior to elective procedures in chronic liver diseases: review of current evidence. Int J Hepatol. 2016, 2016:1802932. 10.1155\/2016\/1802932","journal-title":"Int J Hepatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1211471","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Lisman T","year":"2012","unstructured":"Lisman T, Porte RJ. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012, 367:2055-6. 10.1056\/NEJMc1211471","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal NH","year":"2012","unstructured":"Afdhal NH, Giannini EG, Tayyab G, et al.. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012, 367:716-24. 10.1056\/NEJMoa1110709","journal-title":"N Engl J Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6506.1377","article-title":"Desmopressin and bleeding time in patients with cirrhosis","volume":"291","author":"Burroughs AK","year":"1985","unstructured":"Burroughs AK, Matthews K, Qadiri M, Thomas N, Kernoff P, Tuddenham E, McIntyre N. Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed). 1985, 291:1377-81. 10.1136\/bmj.291.6506.1377","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)02111-5","article-title":"Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group","volume":"355","author":"Porte RJ","year":"2000","unstructured":"Porte RJ, Molenaar IQ, Begliomini B, et al.. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet. 2000, 355:1303-9. 10.1016\/s0140-6736(00)02111-5","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-13-22","article-title":"Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial","volume":"13","author":"Arshad F","year":"2013","unstructured":"Arshad F, Ickx B, van Beem RT, et al.. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013, 13:22. 10.1186\/1471-2482-13-22","journal-title":"BMC Surg"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.05.144","article-title":"Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial","volume":"42","author":"Wang SC","year":"2010","unstructured":"Wang SC, Shieh JF, Chang KY, et al.. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010, 42:2590-3. 10.1016\/j.transproceed.2010.05.144","journal-title":"Transplant Proc"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2177","article-title":"Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease","volume":"137","author":"Dabbagh O","year":"2010","unstructured":"Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010, 137:1145-9. 10.1378\/chest.09-2177","journal-title":"Chest"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-9-201111010-00011","article-title":"Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians","volume":"155","author":"Qaseem A","year":"2011","unstructured":"Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011, 155:625-32. 10.7326\/0003-4819-155-9-201111010-00011","journal-title":"Ann Intern Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26998","article-title":"Treatment of acute portal vein thrombosis by nontraditional anticoagulation","volume":"60","author":"Martinez M","year":"2014","unstructured":"Martinez M, Tandra A, Vuppalanchi R. Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology. 2014, 60:425-6. 10.1002\/hep.26998","journal-title":"Hepatology"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02489.x","article-title":"Towards a rational use of low-molecular-weight heparin in patients with cirrhosis","volume":"31","author":"Lisman T","year":"2011","unstructured":"Lisman T, Porte RJ. Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int. 2011, 31:1063. 10.1111\/j.1478-3231.2011.02489.x","journal-title":"Liver Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann LP","year":"2011","unstructured":"Bechmann LP, Sichau M, Wichert M, Gerken G, Kr\u00f6ger K, Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int. 2011, 31:75-82. 10.1111\/j.1478-3231.2010.02358.x","journal-title":"Liver Int"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-85453-8_253","article-title":"The bleeding time after liver biopsy does not correlate with peripheral coagulation factors","volume":"1","author":"Ewe K","year":"1978","unstructured":"Ewe K, Reinhardt P, M\u00fcller H, Ohler W. The bleeding time after liver biopsy does not correlate with peripheral coagulation factors.  Inn Med. 1978, 1:1060-2. 10.1007\/978-3-642-85453-8_253","journal-title":"Inn Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01822.x","article-title":"Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory","volume":"7","author":"Trotter JF","year":"2007","unstructured":"Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant. 2007, 7:1624-8. 10.1111\/j.1600-6143.2007.01822.x","journal-title":"Am J Transplant"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.03.026","article-title":"Rivaroxaban postmarketing risk of liver injury","volume":"61","author":"Russmann S","year":"2014","unstructured":"Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, H\u00fcrlimann S, Kullak-Ublick GA. Rivaroxaban postmarketing risk of liver injury. J Hepatol. 2014, 61:293-300. 10.1016\/j.jhep.2014.03.026","journal-title":"J Hepatol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305288","article-title":"Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis","volume":"100","author":"Caldeira D","year":"2014","unstructured":"Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, Costa J. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart. 2014, 100:550-6. 10.1136\/heartjnl-2013-305288","journal-title":"Heart"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.11.008","article-title":"Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial","volume":"135","author":"Prins MH","year":"2015","unstructured":"Prins MH, Bamber L, Cano SJ, Wang MY, Erkens P, Bauersachs R, Lensing AW. Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial. Thromb Res. 2015, 135:281-8. 10.1016\/j.thromres.2014.11.008","journal-title":"Thromb Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.027","article-title":"Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats","volume":"59","author":"Lisman T","year":"2013","unstructured":"Lisman T, Kamphuisen PW, Northup PG, Porte RJ. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol. 2013, 59:358-66. 10.1016\/j.jhep.2013.03.027","journal-title":"J Hepatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang Z","year":"2016","unstructured":"Wang Z, Jiang MS, Zhang HL, Weng NN, Luo XF, Li X, Yang L. Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology. 2016, 279:943-51. 10.1148\/radiol.2015150369","journal-title":"Radiology"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen H","year":"2016","unstructured":"Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016, 28:82-9. 10.1097\/MEG.0000000000000482","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung JW","year":"2014","unstructured":"Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol. 2014, 20:384-91. 10.3350\/cmh.2014.20.4.384","journal-title":"Clin Mol Hepatol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo M","year":"2012","unstructured":"Senzolo M, M Sartori T, Rossetto V, et al.. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012, 32:919-27. 10.1111\/j.1478-3231.2012.02785.x","journal-title":"Liver Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86047-cirrhosis-and-coagulopathy-mechanisms-of-hemostasis-changes-in-liver-failure-and-their-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:11Z","timestamp":1707507911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86047-cirrhosis-and-coagulopathy-mechanisms-of-hemostasis-changes-in-liver-failure-and-their-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":75,"URL":"https:\/\/doi.org\/10.7759\/cureus.23785","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,3]]}}}